Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06199492

Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures

Led by M.D. Anderson Cancer Center · Updated on 2026-01-14

150

Participants Needed

1

Research Sites

129 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To learn if an investigational imaging device can help to identify tumor tissue before a biopsy is taken.

CONDITIONS

Official Title

Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have a primary or suspected diagnosis of malignancy with radiographic evidence of malignant lesions in lymph node, liver, or lung
  • Target lesion must be suitable for image-guided biopsy
  • Target lesion size must be at least 1 cm
  • Age 18 years or older at consent
  • Life expectancy of at least 3 months
  • Platelet count greater than 50,000/mm3 within 6 weeks of screening
  • INR less than 1.5 within 6 weeks of screening
  • If using antiplatelet or anticoagulant medication, able to stop it 48 hours before procedure or as directed by the investigator
  • ECOG performance status of 2 or less within 6 weeks of screening
  • Female participants must be post-menopausal or have a negative pregnancy test if pre-menopausal, with specific criteria based on age and hormonal status
  • Prior systemic therapies allowed, including chemotherapy, immunotherapy, and targeted therapy
  • Ability to understand and sign informed consent
Not Eligible

You will not qualify if you...

  • Uncontrolled illnesses such as active infection, interstitial lung disease, symptomatic heart failure, unstable angina, cardiac arrhythmia, or psychiatric/social conditions affecting study compliance
  • Pregnant or nursing women; women of childbearing potential not using effective contraception
  • Absolute neutrophil count less than 1000/mm3 within 6 weeks of screening
  • Active infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MD Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

R

Rahul A Sheth, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here